Table 4.
Death rates for 2003–2007 and fixed-interval trends for 1998–2007 for the top 15 cancers* by sex, race, and ethnicity in the United States†
| Sex/cancer site or type* | All races/ethnicities |
White‡ |
Black‡ |
API‡ |
AI/AN (CHSDA counties)‡ |
Hispanic‡,§ |
Non-Hispanic‡,§ |
|||||||||||||||
| Rank | Rate‖ | 1998–2007 AAPC¶ | 2003–2007 AAPC¶ | Rank | Rate‖ | 1998–2007 AAPC¶ | Rank | Rate‖ | 1998–2007 AAPC¶ | Rank | Rate‖ | 1998–2007 AAPC¶ | Rank | Rate‖ | 1998–2007 AAPC¶ | Rank | Rate‖ | 1998–2007 AAPC¶ | Rank | Rate‖ | 1998–2007 AAPC¶ | |
| All malignant cancers | ||||||||||||||||||||||
| Both sexes | 183.8 | −1.3# | −1.6# | 182.4 | −1.2# | 224.2 | −2.0# | 110.8 | −1.6# | 156.7 | −0.5 | 122.1 | −1.8# | 188.3 | −1.2# | |||||||
| Men | 225.4 | −1.8# | −1.8# | 222.5 | −1.7# | 296.5 | −2.6# | 134.2 | −2.0# | 183.7 | −1.0# | 150.6 | −2.5# | 230.8 | −1.7# | |||||||
| Women | 155.4 | −1.1# | −1.4# | 155.0 | −1.0# | 180.6 | −1.4# | 94.1 | −1.2# | 138.0 | −0.2 | 102.3 | −1.3# | 159.3 | −1.0# | |||||||
| Children age 0–14 y | 2.4 | −1.0# | −3.0# | 2.4 | −0.9# | 2.3 | −0.7 | 2.1 | −2.0 | 1.5 | ** | 2.5 | −1.3 | 2.4 | −1.0# | |||||||
| Children ages 0–19 y | 2.6 | −1.3# | −2.9# | 2.7 | −1.1# | 2.5 | −1.5# | 2.3 | −2.0# | 2.1 | 1.9 | 2.8 | −0.7 | 2.6 | −1.5# | |||||||
| Men | ||||||||||||||||||||||
| Lung and bronchus | 1 | 68.8 | −2.1# | −2.1# | 1 | 68.3 | −1.9# | 1 | 87.5 | −2.9# | 1 | 36.7 | −1.7# | 1 | 48.1 | −2.2# | 1 | 32.5 | −3.3# | 1 | 71.7 | −1.9# |
| Prostate | 2 | 24.7 | −3.9# | −3.9# | 2 | 22.8 | −3.8# | 2 | 54.2 | −4.2# | 4 | 10.6 | −3.1# | 2 | 20.0 | −1.6 | 2 | 18.8 | −3.8# | 2 | 25.0 | −3.8# |
| Colon and rectum | 3 | 21.2 | −2.8# | −3.3# | 3 | 20.6 | −2.9# | 3 | 30.5 | −1.9# | 3 | 13.2 | −3.1# | 3 | 19.2 | −1.8 | 3 | 15.6 | −2.6# | 3 | 21.6 | −2.7# |
| Pancreas | 4 | 12.3 | 0.2 | 0.9# | 4 | 12.2 | 0.4# | 4 | 15.4 | −0.7# | 6 | 8.2 | 0.0 | 5 | 9.9 | 3.5 | 5 | 9.1 | −0.4 | 4 | 12.6 | 0.4# |
| Leukemia | 5 | 9.7 | −0.8# | −1.2# | 5 | 10.0 | −0.6# | 8 | 8.4 | −1.3# | 8 | 4.9 | −1.0 | 9 | 5.8 | 0.1 | 8 | 6.0 | −1.7# | 5 | 9.9 | −0.7# |
| Non-Hodgkin lymphoma | 6 | 8.7 | −3.0# | −3.0# | 6 | 9.1 | −3.0# | 11 | 6.0 | −2.7# | 7 | 5.5 | −2.8# | 10 | 5.3 | −3.7 | 7 | 6.4 | −3.4# | 6 | 8.9 | −2.9# |
| Esophagus | 7 | 7.8 | 0.2 | 0.2 | 8 | 7.9 | 0.9# | 7 | 8.9 | −4.4# | 9 | 3.2 | −2.0 | 8 | 6.4 | 0.0 | 10 | 4.0 | −2.1# | 7 | 8.0 | 0.3# |
| Liver and intrahepatic bile duct | 8 | 7.7 | 2.2# | 2.2# | 9 | 7.0 | 2.2# | 5 | 11.1 | 2.6# | 2 | 14.7 | −1.1# | 4 | 10.9 | 2.2 | 4 | 11.3 | 1.0# | 9 | 7.4 | 2.2# |
| Urinary bladder | 9 | 7.5 | −0.1 | −0.1 | 7 | 7.9 | 0.0 | 13 | 5.4 | −0.3 | 12 | 2.6 | −2.8# | 13 | 3.0 | †† | 11 | 3.9 | −0.9 | 8 | 7.8 | 0.0 |
| Kidney and renal pelvis | 10 | 5.9 | −0.7# | −0.7# | 10 | 6.0 | −0.7# | 12 | 6.0 | −0.6# | 11 | 2.6 | 0.2 | 7 | 8.8 | −0.7 | 9 | 5.2 | −0.3 | 10 | 5.9 | −0.7# |
| Stomach | 11 | 5.3 | −3.5# | −3.5# | 12 | 4.6 | −3.7# | 6 | 10.7 | −3.5# | 5 | 9.4 | −3.6# | 6 | 9.2 | −1.7 | 6 | 8.0 | −3.7# | 12 | 5.1 | −3.7# |
| Brain and other nervous system | 12 | 5.2 | −1.3# | −1.3# | 11 | 5.6 | −1.1# | 15 | 3.1 | −1.5# | 13 | 2.3 | −1.2 | 14 | 2.7 | 3.1 | 13 | 3.2 | −1.3# | 11 | 5.4 | −1.1# |
| Myeloma | 13 | 4.4 | −1.0# | −1.0# | 14 | 4.2 | −0.9# | 9 | 8.1 | −1.7# | 14 | 2.0 | −0.9 | 11 | 4.2 | −0.6 | 12 | 3.3 | −1.4 | 13 | 4.5 | −0.9# |
| Melanoma of the skin | 14 | 4.0 | 0.3 | 0.3 | 13 | 4.5 | 0.5 | 21 | 0.5 | 1.2 | 20 | 0.4 | †† | 16 | 1.6 | †† | 16 | 1.0 | −1.5 | 14 | 4.3 | 0.6# |
| Oral cavity and pharynx | 15 | 3.9 | −1.5# | −1.5# | 15 | 3.7 | −1.1# | 10 | 6.3 | −3.1# | 10 | 3.1 | −2.8# | 12 | 3.5 | −3.2 | 14 | 2.5 | −3.8# | 15 | 4.0 | −1.3# |
| Larynx | 16 | 2.2 | −2.4# | −2.4# | 16 | 2.0 | −2.2# | 14 | 4.6 | −2.8# | 16 | 0.8 | −1.8 | 15 | 1.9 | †† | 15 | 1.8 | −6.4# | 16 | 2.3 | −2.2# |
| Soft tissue including heart | 17 | 1.4 | −0.9# | 1.2# | 18 | 1.5 | −0.7 | 16 | 1.4 | −2.9# | 15 | 1.0 | −0.6 | 18 | 1.0 | †† | 17 | 1.0 | −2.7# | 17 | 1.5 | −0.7 |
| Women | ||||||||||||||||||||||
| Lung and bronchus | 1 | 40.6 | −0.2 | −0.2 | 1 | 41.6 | −0.1 | 1 | 39.6 | −0.3 | 1 | 18.5 | −0.6 | 1 | 33.3 | 1.2 | 2 | 14.4 | −0.4 | 1 | 42.6 | 0.0 |
| Breast | 2 | 24.0 | −2.0# | −2.0# | 2 | 23.4 | −2.0# | 2 | 32.4 | −1.4# | 2 | 12.2 | −1.0# | 2 | 17.6 | 1.1 | 1 | 15.3 | −1.9# | 2 | 24.7 | −1.8# |
| Colon and rectum | 3 | 14.9 | −2.6# | −2.8# | 3 | 14.4 | −2.7# | 3 | 21.0 | −2.7# | 3 | 9.9 | −1.5# | 3 | 12.9 | −2.3 | 3 | 10.5 | −1.5# | 3 | 15.2 | −2.6# |
| Pancreas | 4 | 9.4 | 0.3# | 0.3# | 4 | 9.1 | 0.4# | 4 | 12.4 | −0.2 | 4 | 6.9 | 0.1 | 4 | 8.0 | 1.6 | 4 | 7.5 | 0.2 | 4 | 9.5 | 0.3# |
| Ovary | 5 | 8.6 | −0.5# | −1.7# | 5 | 8.9 | −0.5# | 6 | 7.2 | −1.1# | 7 | 4.9 | 0.6 | 5 | 6.8 | 0.2 | 5 | 6.0 | −0.1 | 5 | 8.8 | −0.4# |
| Non-Hodgkin lymphoma | 6 | 5.5 | −3.4# | −3.1# | 6 | 5.7 | −3.4# | 11 | 3.9 | −2.6# | 8 | 3.5 | −3.4# | 7 | 4.6 | −0.7 | 8 | 4.4 | −2.8# | 6 | 5.6 | −3.5# |
| Leukemia | 7 | 5.4 | −1.4# | −1.4# | 7 | 5.6 | −1.3# | 9 | 5.0 | −1.5# | 9 | 2.9 | −2.1# | 9 | 3.9 | †† | 9 | 3.9 | −1.7# | 7 | 5.5 | −1.1# |
| Corpus and uterus, NOS | 8 | 4.1 | 0.2# | 0.2# | 8 | 3.9 | 0.1 | 5 | 7.2 | 0.8# | 10 | 2.5 | 1.5 | 13 | 2.9 | †† | 11 | 3.0 | −0.9 | 8 | 4.2 | 0.3# |
| Brain and other nervous system | 9 | 3.5 | −1.2# | −1.2# | 9 | 3.8 | −1.1# | 16 | 2.0 | −1.6# | 12 | 1.6 | 1.2 | 17 | 1.6 | †† | 13 | 2.4 | −0.7 | 9 | 3.6 | −1.1# |
| Liver and intrahepatic bile duct | 10 | 3.2 | 1.4# | 1.4# | 10 | 3.0 | 1.6# | 12 | 3.9 | 0.4 | 5 | 6.4 | −1.2 | 6 | 6.6 | 1.4 | 6 | 5.2 | 0.5 | 10 | 3.1 | 1.3# |
| Myeloma | 11 | 2.9 | −1.5# | −2.2# | 12 | 2.7 | −1.4# | 7 | 5.8 | −2.3# | 13 | 1.4 | −1.8 | 12 | 3.0 | −4.2 | 12 | 2.5 | −1.0 | 11 | 2.9 | −1.6# |
| Stomach | 12 | 2.7 | −3.0# | −3.0# | 13 | 2.4 | −3.1# | 8 | 5.0 | −4.0# | 6 | 5.6 | −3.5# | 8 | 4.2 | −5.9# | 7 | 4.6 | −3.0# | 13 | 2.6 | −3.2# |
| Kidney and renal pelvis | 13 | 2.7 | −0.6# | −0.6# | 11 | 2.7 | −0.5# | 14 | 2.7 | −0.2 | 15 | 1.2 | −0.1 | 10 | 3.8 | −2.5 | 14 | 2.4 | −0.5 | 12 | 2.7 | −0.5# |
| Cervix uteri | 14 | 2.4 | −2.2# | −0.7 | 15 | 2.2 | −2.0# | 10 | 4.4 | −3.5# | 11 | 2.1 | −4.6# | 11 | 3.4 | −2.4 | 10 | 3.1 | −2.3# | 14 | 2.4 | −2.3# |
| Urinary bladder | 15 | 2.2 | −0.6# | −0.6# | 14 | 2.2 | −0.4# | 13 | 2.7 | −1.1# | 16 | 0.9 | −0.4 | 19 | 0.9 | †† | 15 | 1.3 | −0.7 | 15 | 2.3 | −0.4 |
| Esophagus | 17 | 1.7 | −1.4# | −1.4# | 17 | 1.6 | −0.7# | 15 | 2.5 | −4.6# | 17 | 0.8 | −0.7 | 15 | 1.7 | †† | 18 | 0.8 | −3.5# | 17 | 1.7 | −1.2# |
| Oral cavity and pharynx | 18 | 1.4 | −2.1# | −2.1# | 18 | 1.4 | −1.9# | 17 | 1.5 | −3.8# | 14 | 1.2 | −0.9 | 16 | 1.6 | †† | 19 | 0.8 | −2.0 | 18 | 1.5 | −2.0# |
| Gallbladder | 20 | 0.8 | −2.1# | −2.1# | 20 | 0.8 | −2.3# | 19 | 0.9 | −0.6 | 18 | 0.8 | −7.3# | 14 | 2.4 | †† | 16 | 1.2 | −5.3# | 20 | 0.7 | −1.9# |
Cancers are sorted in descending order according to sex-specific rates for all races/ethnicities. More than 15 cancers may appear under men and women to include the top 15 cancers in every race/ethnicity group.
AAPC = average annual percent change; AI/AN = American Indian/Alaska Native; APC = annual percent change; API = Asian/Pacific Islander; CHSDA = Contract Health Services Delivery Area; IHS = Indian Health Service; NOS = not otherwise specified. Source: National Center for Health Statistics mortality file for the total United States.
White, black, API, and AI/AN (CHSDA counties) populations include Hispanic and non-Hispanic; the race and ethnicity categories are not mutually exclusive.
Data for Hispanic and non-Hispanic exclude the District of Columbia, Maine, Minnesota, New Hampshire, and North Dakota.
Incidence rates are per 100 000 persons and were age standardized to the 2000 US standard population (19 age groups: <1, 1–4, 5–9, 10–14, … , 80–84, ≥85 years, Census P25–1130).
AAPC is a weighted average of the APCs calculated by Joinpoint over the time period 1998–2007 unless otherwise noted. Joinpoint analyses with up to two joinpoints are based on rates per 100 000 persons and were age standardized to the 2000 US standard population (19 age groups: <1, 1–4, 5–9, 10–14, … , 80–84, ≥85 years, Census P25–1130). Joinpoint Regression Program, Version 3.4.3. April 2010, Surveillance Research Program, National Cancer Institute.
AAPC is statistically significantly different from zero (two-sided Z test, P < .05).
Joinpoint cannot process records with weight variable less than or equal to zero.
Statistic could not be calculated. The AAPC is based on fewer than 10 cancer cases for at least 1 year within the time interval.